TScan Therapeutics Inc (TCRX)
7.785
-0.22
(-2.81%)
USD |
NASDAQ |
May 09, 16:00
7.785
0.00 (0.00%)
After-Hours: 20:00
TScan Therapeutics Price: 7.785 for May 9, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 08, 2024 | 8.72 | 8.724 | 7.98 | 8.01 | 111212.0 |
May 07, 2024 | 8.74 | 8.948 | 8.575 | 8.67 | 107057.0 |
May 06, 2024 | 8.60 | 8.91 | 8.42 | 8.81 | 97441.00 |
May 03, 2024 | 8.79 | 9.09 | 8.55 | 8.56 | 88682.00 |
May 02, 2024 | 8.76 | 8.810 | 8.55 | 8.65 | 229282.0 |
May 01, 2024 | 7.75 | 8.70 | 7.75 | 8.62 | 263587.0 |
Apr 30, 2024 | 7.56 | 7.90 | 7.38 | 7.72 | 289874.0 |
Apr 29, 2024 | 7.41 | 7.815 | 7.41 | 7.68 | 205982.0 |
Apr 26, 2024 | 7.34 | 7.46 | 7.116 | 7.32 | 92052.00 |
Apr 25, 2024 | 7.26 | 7.457 | 7.035 | 7.29 | 107354.0 |
Apr 24, 2024 | 7.28 | 7.51 | 7.11 | 7.38 | 90771.00 |
Apr 23, 2024 | 7.22 | 7.55 | 7.02 | 7.26 | 208344.0 |
Apr 22, 2024 | 6.82 | 7.24 | 6.74 | 7.12 | 173228.0 |
Apr 19, 2024 | 6.82 | 7.13 | 6.71 | 6.82 | 278857.0 |
Apr 18, 2024 | 6.75 | 7.14 | 6.65 | 6.92 | 250511.0 |
Apr 17, 2024 | 7.27 | 7.36 | 6.58 | 6.75 | 1.642M |
Apr 16, 2024 | 7.50 | 7.554 | 7.12 | 7.13 | 98778.00 |
Apr 15, 2024 | 7.49 | 7.924 | 7.435 | 7.69 | 121516.0 |
Apr 12, 2024 | 7.84 | 8.12 | 7.49 | 7.75 | 128946.0 |
Apr 11, 2024 | 7.23 | 7.87 | 7.21 | 7.80 | 168253.0 |
Apr 10, 2024 | 7.29 | 7.41 | 7.08 | 7.23 | 131547.0 |
Apr 09, 2024 | 7.45 | 7.82 | 7.35 | 7.45 | 94960.00 |
Apr 08, 2024 | 7.22 | 7.36 | 7.03 | 7.34 | 70509.00 |
Apr 05, 2024 | 7.03 | 7.20 | 6.997 | 7.09 | 105838.0 |
Apr 04, 2024 | 7.20 | 7.33 | 6.98 | 7.09 | 161683.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.49
Minimum
Dec 27 2022
13.48
Maximum
Aug 18 2021
4.397
Average
3.30
Median
Sep 09 2022
Price Benchmarks
AnaptysBio Inc | 26.15 |
CEL-SCI Corp | 1.50 |
AIM ImmunoTech Inc | 0.4221 |
IGC Pharma Inc | 0.5195 |
NovaBay Pharmaceuticals Inc | 0.0864 |
Price Related Metrics
PS Ratio | 24.18 |
Price to Book Value | 2.728 |
Earnings Yield | -22.99% |
Market Cap | 411.54M |